These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7699233)

  • 41. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.
    Stauch S; Kircheis G; Adler G; Beckh K; Ditschuneit H; Görtelmeyer R; Hendricks R; Heuser A; Karoff C; Malfertheiner P; Mayer D; Rösch W; Steffens J
    J Hepatol; 1998 May; 28(5):856-64. PubMed ID: 9625322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo.
    Varakanahalli S; Sharma BC; Srivastava S; Sachdeva S; Dahale AS
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):951-958. PubMed ID: 29727385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prevention of hepatic encephalopathy].
    Morillas RM; Sala M; Planas R
    Med Clin (Barc); 2014 Jun; 142(11):512-4. PubMed ID: 24480288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis.
    Gitlin N; Lewis DC; Hinkley L
    J Hepatol; 1986; 3(1):75-82. PubMed ID: 3745889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Dose-response curve and preliminary clinical study of a laxative, lactilol].
    Walder M; Buclin T; Biollaz J; Kitler ME; Schelling JL
    Schweiz Med Wochenschr; 1988 Dec; 118(50):1925-7. PubMed ID: 3222688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy.
    Saxena N; Bhatia M; Joshi YK; Garg PK; Dwivedi SN; Tandon RK
    Liver; 2002 Jun; 22(3):190-7. PubMed ID: 12100568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral glutamine challenge in cirrhotics pre- and post-liver transplantation: a psychometric and analyzed EEG study.
    Oppong KN; Al-Mardini H; Thick M; Record CO
    Hepatology; 1997 Oct; 26(4):870-6. PubMed ID: 9328307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Maharshi S; Puri V; Srivastava S
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1203-9. PubMed ID: 26716736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis.
    Compañy L; Zapater P; Pérez-Mateo M; Jover R
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):519-25. PubMed ID: 20010298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Threshold for transitory diarrhea induced by ingestion of xylitol and lactitol in young male and female adults.
    Oku T; Nakamura S
    J Nutr Sci Vitaminol (Tokyo); 2007 Feb; 53(1):13-20. PubMed ID: 17484374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The diagnosis of subclinical hepatic encephalopathy].
    Słowik A; Ciećko-Michalska I; Bogdał J; Szczudlik A
    Przegl Lek; 2001; 58(12):1059-62. PubMed ID: 12041022
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hepatic encephalopathy and liver transplantation].
    Fehérvári I; Nemes B; Görög D; Gerlei Z; Kóbori L
    Magy Seb; 2012 Apr; 65(2):58-62. PubMed ID: 22512880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
    Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
    Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Normalization of the psychometric hepatic encephalopathy score in Polish population. A prospective, quantified electroencephalography study.
    Wunsch E; Koziarska D; Kotarska K; Nowacki P; Milkiewicz P
    Liver Int; 2013 Oct; 33(9):1332-40. PubMed ID: 23651263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lactitol, a new hydrogenated lactose derivative: intestinal absorption and laxative threshold in normal human subjects.
    Patil DH; Grimble GK; Silk DB
    Br J Nutr; 1987 Mar; 57(2):195-9. PubMed ID: 3552029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis.
    Seo YS; Yim SY; Jung JY; Kim CH; Kim JD; Keum B; An H; Yim HJ; Lee HS; Kim CD; Ryu HS; Um SH
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1695-704. PubMed ID: 22743001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [13-week oral toxicity study of lactitol (NS-4) in dogs followed by 4-week recovery test].
    Okasaki K; Ueda T; Onimaru T; Ikeda H; Nagata T; Nagata R; Hamasu Y; Sumi N
    J Toxicol Sci; 1994 Nov; 19 Suppl 3():327-75. PubMed ID: 7837294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.